about
Learning radiation oncology in Europe: Results of the ESTRO multidisciplinary survey.Do protons and X-rays induce cell-killing in human peripheral blood lymphocytes by different mechanisms?Retrospective assessment of MRI-based volumetric changes of normal tissues in glioma patients following radio(chemo)therapy.Treatment constraints for single dose external beam preoperative partial breast irradiation in early-stage breast cancer.Increasing genomic instability during cancer therapy in a patient with Li-Fraumeni syndrome.Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapy.Role of radiotherapy in extracranial metastatic malignant melanoma in the modern era.The predictive value of nadir neutrophil count during treatment of cervical cancer: Interactions with tumor hypoxia and interstitial fluid pressure (IFP).SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy.Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombus.Effect of heterogeneous radio sensitivity on the survival, alpha beta ratio and biologic effective dose calculation of irradiated mammalian cell populations.Association of lung fluorodeoxyglucose uptake with radiation pneumonitis after concurrent chemoradiation for non-small cell lung cancer.PIK3CA mutation is associated with increased local failure in lung stereotactic body radiation therapy (SBRT).Profiling of a panel of radioresistant prostate cancer cells identifies deregulation of key miRNAs.Age-not Charlson Co-morbidity Index-predicts for mortality after stereotactic ablative radiotherapy for medically inoperable stage I non-small cell lung cancer.Cell-line dependent effects of hypoxia prior to irradiation in squamous cell carcinoma lines.P4HA1: A single-gene surrogate of hypoxia signatures in oral squamous cell carcinoma patients.Anemia, leukocytosis and thrombocytosis as prognostic factors in patients with cervical cancer treated with radical chemoradiotherapy: A retrospective cohort study.Glut-1 expression in small cervical biopsies is prognostic in cervical cancers treated with chemoradiation.SYSTEMS-2: A randomised phase II study of radiotherapy dose escalation for pain control in malignant pleural mesothelioma.PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma, with treatment stratified by MGMT status.The role of Next-Generation Sequencing in tumoral radiosensitivity prediction.Significant tumor shift in patients treated with stereotactic radiosurgery for brain metastasis.Automatic treatment planning improves the clinical quality of head and neck cancer treatment plans.Retrospective methods to estimate radiation dose at the site of breast cancer development after Hodgkin lymphoma radiotherapy.First reported treatment of aggressive hemangioma with intraoperative radiation therapy and kyphoplasty (Kypho-IORT).The HIV protease and PI3K/Akt inhibitor nelfinavir does not improve the curative effect of fractionated irradiation in PC-3 prostate cancer in vitro and in vivo.Clinical and Translational Radiation Oncology, a new player among the radiation oncology journals.Barriers to radiotherapy access at the University College Hospital in Ibadan, Nigeria.The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies.The impact of the IGF-1 system of cancer cells on radiation response - An in vitro study.Skull base or cervical vertebral osteomyelitis following chemoradiotherapy for pharyngeal carcinoma: A serious but treatable complication.Radiomic analysis in prediction of Human Papilloma Virus status.Definitive chemoradiotherapy with low-dose continuous 5-fluorouracil reduces hematological toxicity without compromising survival in esophageal squamous cell carcinoma patients.Combining radiotherapy and ipilimumab induces clinically relevant radiation-induced abscopal effects in metastatic melanoma patients: A systematic review.Improved outcome of treating locally advanced lung cancer with the use of Lattice Radiotherapy (LRT): A case report.Simultaneous integrated prophylactic cranial irradiation in sino-nasal cancer.Perspectives on medical education in radiation oncology and the role of the ESTRO School.A predictive model for residual disease after (chemo) radiotherapy in oropharyngeal carcinoma: Combined radiological and clinical evaluation of tumor response.Dosimetric assessment of an Atlas based automated segmentation for loco-regional radiation therapy of early breast cancer in the Skagen Trial 1: A multi-institutional study.
P1433
Q51415449-1C6AEE99-8EA1-4B82-BC11-1369D50F1112Q51415582-B15F2363-3589-4780-B6EC-F8CB33698838Q51733040-8CF3A604-2556-4B9A-842E-9379F7E0613DQ51733043-70CBAB8B-4E1D-4733-A693-61C524A3A115Q52338512-2F72C7F1-176F-4D72-8F82-E360E242324EQ52385231-CF68AB49-A594-4E1D-A347-CA2E31FE590BQ52624075-B9224E0F-931D-40A1-BE83-A2062EF584FFQ52624077-B69017F0-15AF-4106-B84E-C59FC121D137Q52624081-AD692F0B-E09B-4E77-8604-FC58518E3ED2Q52624083-ED18A20C-CB89-4DF1-884D-A76E6157F37DQ52624085-4318FC59-59E4-429D-96DD-AF26E9D51C52Q52624089-5478775B-C080-49C7-A635-928AFB22DA18Q52674758-7B46C287-DED8-41B1-9755-50FF7EF30851Q52721513-93693559-544F-4A9D-B110-55F9451A8B86Q52723380-9543EEBC-C318-4043-9C7F-C7B6B00224CAQ52723382-2831345C-D6A3-4E17-8F3B-F37DBC8F7269Q52723384-E603CA3C-81B8-47ED-AF31-78C26F1F65B6Q52723387-D06D9FA2-7A7F-48DA-9D4A-541BD031656BQ52794306-1F7768B9-0D1B-4510-9666-08114C2AE5ADQ52802449-021CE395-1FEF-4558-B490-A63BF28C60DCQ52802452-9D64DEED-2178-485B-836C-B8F6B6AC8408Q52805099-6002876E-3F8C-4A7C-ABF8-C893EA8925ABQ52842249-49F176CD-6470-4825-8908-203250BF4275Q52920293-A6E5DE97-8366-4C1B-844A-866F97D5C370Q53176639-8B9ADBFF-0FB8-4B57-81D8-857E93540FD0Q53550985-175BCFDE-FB51-408D-8DDD-91BD004ACB8FQ53596358-25D67F9C-03FB-4726-ACB2-26E2E1EFA349Q53620815-50880157-0E0A-418A-B6E5-AB12873C3F90Q53697644-6FD97F21-2421-41E0-85DF-98FFD35F06D0Q53823206-109E723F-14EC-41EF-AB6E-17416AEFF45AQ54118814-E4F8DA7B-0443-4950-8FD3-97371F0299FEQ54246266-F34F6F99-613B-4BDE-9A3E-7367F9514DF2Q54246270-EFADF3FA-73AC-4ECE-9651-67227B15C5FCQ54267061-BB85B7C2-CA12-405C-937C-F0B847C22CD3Q54933769-1EEA1F36-DB00-45F1-B47F-DA0C2A9D9083Q54940866-413248A2-5194-45CC-8A94-65EC6DF44766Q54942085-3E1FA3EA-F879-4D2D-B6F0-557CD9FA05FAQ54962409-433151AF-680C-4CE3-9CF9-FE9A2C98BBC5Q54963405-6D895E44-B7B3-4E4D-8ABC-E7F253CAF6E4Q54980429-42D97DAB-150D-4015-AE9F-FFCE1645C421
P1433
description
Academic journal published by ...... cluding cancer and carcinogens
@en
academisch tijdschrift
@nl
name
Clinical and Translational Radiation Oncology
@en
Clinical and Translational Radiation Oncology
@nl
type
label
Clinical and Translational Radiation Oncology
@en
Clinical and Translational Radiation Oncology
@nl
prefLabel
Clinical and Translational Radiation Oncology
@en
Clinical and Translational Radiation Oncology
@nl
P1055
P17
P236
P5115
P5963
clinical-and-translational-radiation-oncology